Cargando…

SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city

BACKGROUND: Patients with COVID-19 are follow-up in primary care and long COVID is scarcely defined. The study aim was to describe SARS-CoV-2 pneumonia and cut-offs for defining long COVID in primary care follow-up patients. METHODS: A retrospective observational study in primary care in Madrid, Spa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ares-Blanco, Sara, Pérez Álvarez, Marta, Gefaell Larrondo, Ileana, Muñoz, Cristina, Aguilar Ruiz, Vanesa, Castelo Jurado, Marta, Guisado-Clavero, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457448/
https://www.ncbi.nlm.nih.gov/pubmed/34551007
http://dx.doi.org/10.1371/journal.pone.0257604
_version_ 1784571097325240320
author Ares-Blanco, Sara
Pérez Álvarez, Marta
Gefaell Larrondo, Ileana
Muñoz, Cristina
Aguilar Ruiz, Vanesa
Castelo Jurado, Marta
Guisado-Clavero, Marina
author_facet Ares-Blanco, Sara
Pérez Álvarez, Marta
Gefaell Larrondo, Ileana
Muñoz, Cristina
Aguilar Ruiz, Vanesa
Castelo Jurado, Marta
Guisado-Clavero, Marina
author_sort Ares-Blanco, Sara
collection PubMed
description BACKGROUND: Patients with COVID-19 are follow-up in primary care and long COVID is scarcely defined. The study aim was to describe SARS-CoV-2 pneumonia and cut-offs for defining long COVID in primary care follow-up patients. METHODS: A retrospective observational study in primary care in Madrid, Spain, was conducted. Data was collected during 6 months (April to September) in 2020, during COVID-19 first wave, from patients ≥ 18 years with SARS-CoV-2 pneumonia diagnosed. Variables: sociodemographic, comorbidities, COVID-19 symptoms and complications, laboratory test and chest X-ray. Descriptive statistics were used, mean (standard deviation (SD)) and medians (interquartile range (IQR)) respectively. Differences were detected applying X(2) test, Student’s T-test, ANOVA, Wilcoxon-Mann-Whitney or Kruskal-Wallis depending on variable characteristics. RESULTS: 155 patients presented pneumonia in day 7.8 from the onset (79.4% were hospitalized, median length of 7.0 days (IQR: 3.0, 13.0)). After discharge, the follow-up lasted 54.0 median days (IQR 42.0, 88.0) and 12.2 mean (SD 6.4) phone calls were registered per patient. The main symptoms and their duration were: cough (41.9%, 12 days), dyspnoea (31.0%, 15 days), asthenia (26.5%, 21 days). Different cut-off points were applied for long COVID and week 4 was considered the best milestone (28.3% of the sample still had symptoms after week 4) versus week 12 (8.3%). Patients who still had symptoms >4 weeks follow-up took place over 81.0 days (IQR: 50.5, 103.0), their symptoms were more prevalent and lasted longer than those ≤ 4 weeks: cough (63.6% 30 days), dyspnoea (54.6%, 46 days), and asthenia (56.8%, 29 days). Embolism was more frequent in patients who still had symptoms >4 weeks than those with symptoms ≤4 weeks (9.1% vs 1.8%, p value 0.034). CONCLUSION: Most patients with SARS-CoV-2 pneumonia recovered during the first 4 weeks from the beginning of the infection. The cut-off point to define long COVID, as persisting symptoms, should be between 4 to 12 weeks from the onset of the symptoms.
format Online
Article
Text
id pubmed-8457448
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-84574482021-09-23 SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city Ares-Blanco, Sara Pérez Álvarez, Marta Gefaell Larrondo, Ileana Muñoz, Cristina Aguilar Ruiz, Vanesa Castelo Jurado, Marta Guisado-Clavero, Marina PLoS One Research Article BACKGROUND: Patients with COVID-19 are follow-up in primary care and long COVID is scarcely defined. The study aim was to describe SARS-CoV-2 pneumonia and cut-offs for defining long COVID in primary care follow-up patients. METHODS: A retrospective observational study in primary care in Madrid, Spain, was conducted. Data was collected during 6 months (April to September) in 2020, during COVID-19 first wave, from patients ≥ 18 years with SARS-CoV-2 pneumonia diagnosed. Variables: sociodemographic, comorbidities, COVID-19 symptoms and complications, laboratory test and chest X-ray. Descriptive statistics were used, mean (standard deviation (SD)) and medians (interquartile range (IQR)) respectively. Differences were detected applying X(2) test, Student’s T-test, ANOVA, Wilcoxon-Mann-Whitney or Kruskal-Wallis depending on variable characteristics. RESULTS: 155 patients presented pneumonia in day 7.8 from the onset (79.4% were hospitalized, median length of 7.0 days (IQR: 3.0, 13.0)). After discharge, the follow-up lasted 54.0 median days (IQR 42.0, 88.0) and 12.2 mean (SD 6.4) phone calls were registered per patient. The main symptoms and their duration were: cough (41.9%, 12 days), dyspnoea (31.0%, 15 days), asthenia (26.5%, 21 days). Different cut-off points were applied for long COVID and week 4 was considered the best milestone (28.3% of the sample still had symptoms after week 4) versus week 12 (8.3%). Patients who still had symptoms >4 weeks follow-up took place over 81.0 days (IQR: 50.5, 103.0), their symptoms were more prevalent and lasted longer than those ≤ 4 weeks: cough (63.6% 30 days), dyspnoea (54.6%, 46 days), and asthenia (56.8%, 29 days). Embolism was more frequent in patients who still had symptoms >4 weeks than those with symptoms ≤4 weeks (9.1% vs 1.8%, p value 0.034). CONCLUSION: Most patients with SARS-CoV-2 pneumonia recovered during the first 4 weeks from the beginning of the infection. The cut-off point to define long COVID, as persisting symptoms, should be between 4 to 12 weeks from the onset of the symptoms. Public Library of Science 2021-09-22 /pmc/articles/PMC8457448/ /pubmed/34551007 http://dx.doi.org/10.1371/journal.pone.0257604 Text en © 2021 Ares-Blanco et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ares-Blanco, Sara
Pérez Álvarez, Marta
Gefaell Larrondo, Ileana
Muñoz, Cristina
Aguilar Ruiz, Vanesa
Castelo Jurado, Marta
Guisado-Clavero, Marina
SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city
title SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city
title_full SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city
title_fullStr SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city
title_full_unstemmed SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city
title_short SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city
title_sort sars-cov-2 pneumonia follow-up and long covid in primary care: a retrospective observational study in madrid city
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457448/
https://www.ncbi.nlm.nih.gov/pubmed/34551007
http://dx.doi.org/10.1371/journal.pone.0257604
work_keys_str_mv AT aresblancosara sarscov2pneumoniafollowupandlongcovidinprimarycarearetrospectiveobservationalstudyinmadridcity
AT perezalvarezmarta sarscov2pneumoniafollowupandlongcovidinprimarycarearetrospectiveobservationalstudyinmadridcity
AT gefaelllarrondoileana sarscov2pneumoniafollowupandlongcovidinprimarycarearetrospectiveobservationalstudyinmadridcity
AT munozcristina sarscov2pneumoniafollowupandlongcovidinprimarycarearetrospectiveobservationalstudyinmadridcity
AT aguilarruizvanesa sarscov2pneumoniafollowupandlongcovidinprimarycarearetrospectiveobservationalstudyinmadridcity
AT castelojuradomarta sarscov2pneumoniafollowupandlongcovidinprimarycarearetrospectiveobservationalstudyinmadridcity
AT guisadoclaveromarina sarscov2pneumoniafollowupandlongcovidinprimarycarearetrospectiveobservationalstudyinmadridcity